MedPath

AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity

Not yet recruiting
Conditions
Systemic Lupus Erythematosus Disease
Registration Number
NCT07043153
Lead Sponsor
Sohag University
Brief Summary

This study aims to evaluate the clinical utility of combining the albumin to globulin ratio (AGR) and the prognostic nutritional index (PNI) as a predictive model for assessing disease activity in patients with systemic lupus erythematosus (SLE). By correlating these nutritional and inflammatory markers with clinical manifestations and laboratory parameters, we hope to establish a simple, non-invasive, and cost-effective tool to aid in monitoring disease activity in Systemic lupus erythematosus patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
140
Inclusion Criteria
  • · Age ≥ 18 years.

    • Both sexes.
    • Patients diagnosed with SLE who fulfilling the Systemic Lupus International Collaborating Clinics (SLICC) classification criteria and matched controls.
Exclusion Criteria
  • Co-existing chronic inflammatory or autoimmune diseases.
  • Age <18 years
  • Malignancy.
  • Pregnancy or lactation.
  • Chronic liver or renal insufficiency.
  • Malignant hematologic diseases.
  • Active hepatitis.
  • Acute infection within the previous four weeks

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
assess the utility of the albumin-to-globulin ratio (AGR) as reliable, non-invasive biomarker for predicting disease activity in patients with systemic lupus erythematosus (SLE).From 6 month to one year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag University hospitals

🇪🇬

Sohag, Egypt

Sohag University hospitals
🇪🇬Sohag, Egypt
Magdy M Amin, Professor
Contact
0934602963
Portal@med.sohag.edu.eg
© Copyright 2025. All Rights Reserved by MedPath